SEC Filing Summary: Charles River Laboratories International, Inc.
Business Context and Reporting Period
This Form 8-K, dated May 7, 2025, reports the issuance of a press release containing financial results for the first quarter ended March 29, 2025. The filing serves as a notification of these results and includes forward-looking statements protected under the Private Securities Litigation Reform Act of 1995.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the attached press release (Exhibit 99.1), which is referenced but not included in the text of this 8-K form.
Material Changes
The filing text does not provide data to compare current period performance against the prior comparable period. Investors must refer to the attached press release for details on material changes in financial condition or results of operations.
Guidance, Outlook, and Risks
The filing notes that the attached press release contains forward-looking statements regarding the company's outlook. It explicitly states that risks relating to Charles River are set forth in other documents filed with the Securities and Exchange Commission. No specific guidance figures or unusual items are detailed in this summary text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 7, 2025) for specific Q1 2025 revenue and earnings figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Examine the "forward-looking statements" section in the press release for updated guidance.
- Consult the company's most recent 10-K or 10-Q filings for detailed risk factors referenced in this report.